The frequencies and distribution of common fragile sites in normal Japanese individuals were studied using lymphocyte chromosome preparations from cultures under folate deprivation, 5-bromodeoxyuridine (BrdU) or aphidicolin treatment. Defining the 4~ level of total breaks as a cut-off point, 13 folate-sensitive, 20 BrdU-induced and 8 aphidicolininduced sites were identified in one or more individuals studied. After eliminating overlapping, 28 fragile sites were identified. Of these, 23 have been reported, while the other five have not been described. Of the latter, those at 4q34 and 6q22 were each found in only one individual. The site at 3q26.2 has not been reported but one at 3q27 has been identified. Excluding these three sites as inconclusive, there remain two sites hitherto undescribed: 1) a folate-sensitive site at 17q21, found in two of eight individuals studied, and 2) a BrdU-requiring site at 13q31, found in five of eight individuals.
INTRODUCTION
Chromosomal fragile sites are now classified into three groups based on their frequencies in the general population (Hecht, 1986) : rare, present in less than 1X of the general population; polymorphic, 1-50~; and common, over 50~. While we agree with the classification, the frequencies of fragile sites vary considerably depending on the means of their induction. We will thus use the term "common" to include both polymorphic and common fragile sites.
Common fragile sites (c-fra) are inducible at low frequencies under culture conditions that induce thymidylate stress (folate and thymidine deprivation, methotrexate or fluorodeoxyuridine treatment), and by 5-bromodeoxyuridine (BrdU) or 5-azacytidine treatment, while they are induced at high frequencies by treatment with aphidicolin, aphidicolin plus ethanol, caffeine, or by a combination of these with other conditions (cf Sutherland and Hecht, 1985; Kuwano and Kajii, 1987, for references) .
Reports on c-fra sites in Caucasians have included those induced by folic acid deprivation (Sutherland, 1979; Yunis and Soreng, 1984; Marlhens et al., 1986) , by treatment with methotrexate (Barbi et al., 1984) , fluorodeoxyuridine (Barbi et al., 1984; Daniel et aL, 1984; Yunis and Soreng, 1984; Rao et al., 1988) , 5-bromodeoxyuridine , 5-azacytidine , caffeine (Yunis and Soreng, 1984) , or aphidicolin (Glover, 1984; Craig-Holmes et al., 1987; Rao et aL, 1988) . Little has been known of their individual or racial difference.
This report will deal with c-fra sites in Japanese individuals induced by folate deprivation, BrdU and aphidicolin.
MATERIALS AND METHODS
Heparinized whole blood samples from healthy Japanese individuals were cultured for 4 days in Eagle's minimum essential medium (MEM) containing 5~ fetal calf serum, 4~ phytohemagglutinin, penicillin and streptomycin.
In one group, blood samples from eight healthy individuals, four males and four females, ranging in age from 7 to 31 years (Subjects 1-8), were cultured in MEM without folio acid or thymidine. Additional samples from the same individ- , [pn. J. Human Genet. uals were cultured in MEM (containing 1.0 mg/liter folic acid) and BrdU was added during the final 6 hr at a final concentration of 20 rag/liter. In another group, cultures from seven healthy individuals, 2 males and 5 females aged 22 to 34 years (Subjects 9-15), were set up using MEM. Aphidicolin, 0.2 t~g dissolved in 0.02~ dimethylsulfoxide, was added during the final 26 hr.
Colcemid was added to both of the above groups 2 hr prior to harvest, and conventional, air-dried chromosome slides were prepared and Giemsa stained. A total of 200 metaphases were scored for gaps and breaks in slides from cultures with folate deprivation and BrdU, and 100 metaphases in those with aphidicolin. The chromosomes were then destained, trypsin-G banded, and their band localization was photographically determined.
The 15 subjects in this study included 6 males and 9 females, ranging in age from 6 to 34 years (Table 1) . None of them smoked, nine took alcoholic beverages only on social occasions, and none had virus infections, was exposed to X-ray, or took drugs during a two-week-period preceding the sampling. Their peripheral blood lymphocytes cultured for 4 days in MEM with 10~ fetal calf serum yielded 2 to 7 breaks per 100 cells screened.
RESULTS

Folate-sensitive c-fra
A total of 536 breaks were observed among 1,600 cells scored ( Table 2 ). The rates of total breaks in 100 cells ranged from 16 to 45.5 among the eight subjects studied, with a mean of 33.5. There were 13 sites that occurred with 4~ or more of total breaks in one or more subjects, accounting for 62.9~ of total fragile sites observed. Of these, seven were present at _>4~ in only one individual. The remaining six sites were seen at _> 4~ in two or more individuals. The most common fragile site was 3p14 with 27.4~ of the total breaks. This site was seen in all eight subjects. Another c-fra site seen in all subjects was 6q26 with a frequency of 10.4~ of total breaks. Other sites of breakage observed in decreasing order of frequency were: 16q23 (5.6~), lp31 (5.2~), 3q26.2 (3.7~), 17q21 (1.7~).
BrdU-sensitive c-fra
A total of 320 breaks were observed among 1,600 cells from cultures with BrdU (Table 3) . Breaks per 100 cells ranged from 15 to 23.5 among the eight individuals studied, with a mean of 20. There were 20 sites that occurred with _> 4~ of total breaks in one or more subjects. They accounted for 58.1~ of the total breaks. Of these, 10 were present at _>4~ in only one individual. The most common site was 5p14 with 9.7~ of the total breaks seen in all subjects. The second common fragile site was 3p14 (8.8~), followed by 9p13 (6.6~), 13q31 (4.4~), 16q23 (3.1~), 3q26.2 (2.5~), 16q22 (2.5~), 5q31 (2.2~), and 8q24 (2.2~). 
Aphidicolin-sensitive c-fra
Among the three treatments, cells treated with aphidicolin showed the highest frequency of fragile sites (Table 4) . A total of 2,058 breaks were observed among 700 cells scored, with a mean of 294 breaks per 100 cells. There were 8 sites that occurred with > 4~ of total breaks in one or more individuals, and accounted for 54.8~ of the total breaks. Of these sites, two were present in only one individual. The most common sites was 3p14 with 17.1~ of the total breaks, followed by 16q23 (13.0~), Xp22 (7.1~), 7q32 (5.4~), 14q24 (4.1~), 6q26 (2.7~), and 2p24 (2.2~).
DISCUSSION
Most of the previous reports on the frequency of a fragile site have been based on the total number of cells that express a fragile site. Hecht and Sutherland (1984) recommended that two or more cells with the same fragile site are necessary to classify the individual as positive for that fragile site. A 4~ cut-off frequency has been suggested for determining the presence of fragile X (Jacobs et al., 1980) . These criteria are acceptable under conditions where the frequency of background fragile sites that are simultaneously expressed in the cells is low. This applies to the common fragile sites induced by folate deprivation or BrdU. The criteria, however, are not acceptable under conditions where the frequency of fragile sites is high, as is the case with aphidicolin or caffeine treatment. Thus, we estimated the frequency of fragile sites in relation to total breaks, as suggested by Rao et aL (1988) .
Using the 4~ level of total breaks as a criterion, 13 folate-sensitive sites, 20 BrdU-induced sites, and 8 aphidicolin-induced sites were identified in one or more , 4, 6, 8, 10 Common to folate deficiency and aphidicolin 21924 6, 9, 2p23 by 8
Common to BrdU and a19hidicolin 7q32 2, 5, 6, 8, 10 Common to all treatments 3p14 2, 3, 4, 5, 6, 8, 9, 10 6q26 3, 4, 5, 6, 8, 10 16q23 2, 3, 4, 5, 6, 8, 9, 10 1, Sutherland (1979); 2, Barbi et al. (1984); 3, Daniel et aL (1984); 4, de la Cha19elle and Berger (1984); 5, Glover (1984); 6, Yunis and Soreng (1984); 7, Sutherland et at. (1985) ; 8, Craig-Holmes et al. (1987); 9, Marlhens et aL (1986); 10, Rao et al. (1988) . individuals in our study. After eliminating overlapping, a total of 28 sites were identified (Table 5) . Of these, 23 (82~) have been reported previously while the remaining five sites, 3@6.2, 4q34, 6q22, 13q31 and 17q2i, have not been described (Fig. 1) . Of the latter five, those at 4q34 and 6@2, both BrdU induced, were each found in only one individual, and thus need further confirmation. The site at 3q26.2, both folate sensitive and BrdU induced, has not been described, but a site at the adjoining band 3q27 has been reported (Glover, 1984; Yunis and Soreng, 1984; Craig-Holmes et al., 1987) . The question of whether or not they are identical remains to be answered. This leaves two sites previously unreported: 1) a folate sensitive site at 17q21, identified in two of eight individuals studied, and 2) a BrdU-requiring site at 13q31, found in five of eight individuals. Takahashi et al. (1988) , in a recent survey of rare fragile sites in Japanese blood donors, reported two new fragile sites: 1) a folate-sensitive site at 17p12, and 2) a distamycin A-inducible site at 8q24.1. Since rare fragiIe sites may result from mutations at common fragile sites, it would be worthwhile to check for their presence among common fragile sites. Neither of these sites, however, was detected in our study.
In conclusion, most of the fragile sites found in our study were common with those reported in various Caucasian populations. Some sites, notably a folatesensitive site at 17q21 and a BrdU-requiring site at 13q31, have not been described in Caucasian populations. It remains to be seen whether these sites represent racial or population difference.
